Company: STAA
Filing Date: 2025-09-16
Form Type: DEFM14A
Source: 0001193125-25-204396
Chunk: 278

Company: STAAR SURGICAL CO
Filing Date: 2025-09-16
Form: DEFM14A
Chunk 278
---
ations, taken as a whole, relative to other medical device companies in similar geographies in which the Acquired Corporations operate, then the incremental disproportionate adverse effect (and only the incremental disproportionate adverse effect) may be taken into account in determining whether a Company Material Adverse Effect has occurred. Material Contract. “ Material Contract” is defined in Section 3.9(a)of the Agreement. Maximum Amount.“ Maximum Amount” is defined in Section 6.5(b)of the Agreement. Merger. “ Merger” is defined in Recital (A)to the Agreement. Merger Consideration. “ Merger Consideration” is defined in Recital (A)to the Agreement. Merger Sub. “ Merger Sub” is defined in the preamble to the Agreement. Merger Sub Sole Stockholder Approval. “ Merger Sub Sole Stockholder Approval” is defined in Recital (D)to the Agreement. MFDS. “ MFDS” shall mean the Ministry of Food and Drug Safety in South Korea. MHRA. “ MHRA” shall mean the Medicines and Healthcare products Regulatory Agency in the United Kingdom. Nasdaq. “ Nasdaq” shall mean The Nasdaq Global Market. New Plan.“ New Plan” is defined in Section 6.3(b)of the Agreement. NMPA. “ NMPA” shall mean the National Medical Products Administration in China (formerly, China Food and Drug Administration). Notice Period. “ Notice Period” is defined in Section 6.1(b)(i)of the Agreement. Old Plan. “ Old Plan” is defined in Section 6.3(b)of the Agreement. Out-of-the-MoneyCompany Option. “ Out-of-the-MoneyCompany Option” is defined in Section 1.6(b)of the Agreement. A-A-9

Parent. “”is defined in the preamble to the
Agreement.

Parent 401(k) Plan. “” is defined in of the
Agreement.

Parent Material Adverse Effect. “” shall mean any event, occurrence,
circumstance, change or effect which, individually or when taken together with all other events, occurrences, circumstances, changes or effects, has had, or would reasonably be expected to have, a material adverse effect on, or has materially
delayed or impaired, or would reasonably be expected to materially delay or impair, the ability of Parent or Merger Sub to perform their obligations under this Agreement and consummate the Transactions on or before the End Date.

Parent